Join the debate! A free on-line multimedia educational activity

TITLE: MS MANAGEMENT: THE IMMUNOSUPPRESSION DEBATE

RELEASE DATE: December 31, 2010
EXPIRATION DATE: December 30, 2011
ESTIMATED TIME TO COMPLETE THIS ACTIVITY: 1.25 hours

MEDIA: Interactive video presentation

TARGET AUDIENCE

This activity is directed to neurologists as well as nurse practitioners and physician assistants with a neurology specialty. It is also appropriate for pharmacy directors and pharmacists.

LEARNING OBJECTIVES FOR THE PROPOSED ACTIVITY

Learners who complete this program will be able to

• List the immunologic pathways that are involved in the pathophysiology of MS
• Identify therapeutic agents that can block specific pathophysiologic pathways in MS
• Identify the types of adverse events that may be associated with blocking immunologic pathways during MS treatment
• Weigh the evidence that immunologically based agents can slow disease progression in MS
• Choose appropriate therapy for patients with various presentations of MS, with an eye toward efficacy and long-term safety

CREDIT

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Annenberg Center for Health Sciences at Eisenhower and the Multiple Sclerosis Educational Alliance.

The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

Annenberg Center designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAPA accepts Category 1 CME credit for the PRA from organizations accredited by ACCME.

Annenberg Center for Health Sciences is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207. This program is accredited for 1.25 contact hours (which includes 0.5 hour of pharmacology). Program ID #4798.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 1.25 contact hours may be earned for successful completion of this activity.

There is no charge for this activity.

Electronic statements of Credit will be issued on line after successful completion of the test and evaluation.

DISCLOSURES

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from their accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

 

Jerry S. Wolinsky, MD

Board Membership: Antisense Therapeutics, BC Decker, Novartis, sanofi-aventis, Teva Pharmaceutical Industries, Eli Lilly, UCB

Consultancy: Genentech, Novartis, sanofi aventis, Teva Neuroscience, Teva Pharmaceuticals, Acorda Therapeutics, Actelion, Bayer HealthCare, Facet Biotech, Peptimmune

Research Support: NIH, sanofi-aventis, Clayton Foundation for Research, National MS Society

Honoraria: Consortium of MS Centers, sanofi-aventis New Zealand, Sterling Meeting Services, USF Health Professionals, Texas Neurological Society, Teva Pharmaceuticals, Lone Star Chapter of National MS Society, Institute for Continuing Healthcare Education, Pfizer/EMD Serono, SUNY Stony Brook Foundation, University of Texas Medical Branch, Medscape CME, University of Buffalo, Serono Symposia International Foundation, University of Utah

Royalties: Millipore Corp

 

Fred Lublin, MD
Consultant: Bayer HealthCare, Biogen Idec, EMD Serono, Genentech, Novartis, Pfizer, Teva Neuroscience, Genmab, MediciNova, Actelion, Allozyne, sanofi-aventis, Acorda Therapeutics, Questcor, Avanir Pharmaceuticals, Roche, Celgene, Abbott Labs, MorphoSys

Speakers Bureau: EMD Serono, Pfizer, Teva Neuroscience

Research Support: Acorda Therapeutics, Biogen Idec, Genentech, Novartis Pharmaceuticals, Teva Neuroscience, Genzyme, sanofi-aventis, NIH, National MS Society

Stock ownership: Cognition Pharmaceuticals

 

Donald A. Barone, DO
Consultant: Biogen Idec, EMD Serono, Teva Neuroscience, Bayer HealthCare, Acorda Therapeutics

Speakers Bureau: Biogen Idec, EMD Serono, Teva Neuroscience, Bayer HealthCare, Acorda Therapeutics, Novartis

Research Support: Biogen Idec, EMD Serono, Teva Neuroscience

 

Richard H. Blanck, MD
Speakers Bureau: Teva, Biogen Idec, Bayer HealthCare, EMD Serono, Pfizer, Acorda Therapeutics

 

Lloyd H. Kasper, MD
Consultant: Teva Neuroscience, Bayer Healthcare, EMD Serono

Speaker’s Bureau: Teva Neuroscience, Bayer Healthcare, EMD Serono

Research Support: Teva Neuroscience, Bayer Healthcare

 

Robert T Keenan, MD, MPH
Speakers Bureau: Novartis

 

Ilya Kister, MD
Research: Biogen Idec, EMD Serono

 

John A. Lincoln, MD, PhD
Consultant: Bayer HealthCare, EMD Serono, Teva Neuroscience, Novartis

Speakers Bureau: Bayer HealthCare

 

Clyde E. Markowitz, MD
Consultant: Biogen Idec, Novartis, Pfizer, Bayer HealthCare, EMD Serono

Research Support: Biogen Idec, Novartis, Teva Neuroscience, EMD Serono, Bayer Healthcare

 

Kaiyo Nedd, MD, CCFP
Nothing to disclose

 

Amy Perrin Ross, APN, MSN, CNRN, MSCN
Consultant: Novartis, Bayer HealthCare, Teva Neuroscience, Allergan, Biogen Idec, Acorda Therapeutics, EMD Serono, Pfizer, Genzyme, Questcor Pharmaceuticals

 

Ram Sriram, MD
Research Support:  EMD Serono

 

Mitzi J. Williams, MD
Consultant: Teva Neuroscience, Biogen Idec, EMD Serrono

Speakers Bureau: Teva Neuroscience, Pfizer, Biogen Idec, Bayer Healthcare

Research Support: Biogen Idec

PLANNING COMMITTEE

Annenberg Center for Health Sciences:
The staff members of the Annenberg Center for Health Sciences have nothing to disclose.

 

MS Educational Alliance:
Stephanie Phillips, PhD:
Nothing to disclose

Lisa Tushla, PhD, H(ASCP):
Nothing to disclose

 

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

SYSTEM REQUIREMENTS

To participate, you will need access to a computer (either MAC or PC) with a Firefox (version 3.6 or greater) web brower or an Internet Explorer (version 8.0 or greater) web browser as well as Adobe Flash player and sound, connected to the Internet (high speed connection preferred).

Contact this provider at cwatlet@annenberg.net

The Annenberg Center for Health Sciences and The Multiple Sclerosis Educational Alliance respect your privacy. We don't share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission.

Internet Privacy Information

For more information about privacy online, cookies, and what a Web server can and cannot learn about you without your cooperation, visit the Center for Democracy and Technology's Privacy page at: http://www.cdt.org/privacy/.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the view of Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account each patient’s unique clinical situation. Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from Biogen Idec, Inc., and Elan Pharmaceuticals.

Successful completion is achieved by viewing the material, reflecting on its implications in your practice, and completing the assessment component.

Copyright © 2010  Multiple Sclerosis Educational Alliance   ACHS 4798